Basic Clopidogrel Information

• INN (International Nonproprietary Name): Clopidogrel.
• Brand Names Available In Canada (English): Plavix; generics such as Clopidogrel Teva, Clopidogrel Mylan, and products from KRKA, Apotex, Sandoz are commonly supplied globally, but specific Canadian brand listings are not specified in the source data.
• ATC Code: B01AC04.
• Forms & Dosages: Tablets 75 mg (primary maintenance dose) and 300 mg (for loading doses); fixed-dose combinations such as clopidogrel 75 mg + aspirin 75 mg exist in other markets.
• Manufacturers In Canada (English): Local manufacturers in Canada are not specified in the source data; known global suppliers include Sanofi-Aventis, Bristol-Myers Squibb (Plavix), KRKA, Teva, Mylan, Pfizer, Apotex and various international generic manufacturers.
• Registration Status In Canada (English): Not specified in the source data.
• OTC / Rx Classification: Prescription-only medicine (Rx).

Availability & Price Landscape

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Canadians generally obtain clopidogrel with a prescription at national chains and community pharmacies.

Clopidogrel is prescription-only across Canada, and large chains such as Shoppers Drug Mart, Rexall, London Drugs and Quebec chains like Jean Coutu routinely stock either brand-name Plavix or multiple generics depending on supply.

Availability can vary by region and supplier, so pharmacists often confirm which manufacturer is in stock and whether a generic substitution is permitted under provincial rules.

Pharmacists can advise on interchangeability and provincial coverage under programs such as Ontario Drug Benefit, BC PharmaCare and RAMQ.

Store-By-Store Checklist:

• Bring your prescription and provincial drug card.
• Ask whether Plavix or a generic (Teva, Mylan, Apotex) is available that day.
• Request a pharmacist consultation about interchangeability and side effects.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Many Canadians use licensed online pharmacies for convenience, click-and-collect or home delivery.

Provincial rules govern dispensing, prescription transfers and electronic prescriptions, so online dispensaries must follow provincial pharmacy regulations.

Cross-border purchasing from the U.S. or international vendors is common, but it carries customs, authenticity and reimbursement risks.

Price Ranges By Package Size (With Provincial Differences)

Prices for clopidogrel vary across provinces, pharmacies and between brand and generic products.

Generics are generally cheaper than Plavix, and a 30-tablet bottle of clopidogrel 75 mg typically has a wide retail price range depending on pharmacy markup and provincial formulary discounts.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may cover clopidogrel under specific indications and eligibility rules, so out-of-pocket cost depends on patient status and program rules.

Patients in rural areas may face higher costs or delays if local pharmacies have limited stock.

A provincial coverage map is useful for patients to check local formulary listings and patient eligibility for reduced cost under public plans.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Canadians discuss clopidogrel on platforms like Reddit (r/AskDocsCanada, r/CanadaHealth), HealthBoards and provincial patient groups.

Common discussion topics include cost, side effects such as easy bruising and bleeding, and questions about switching from brand Plavix to generics like Teva-Clopidogrel or Mylan products.

Many posts describe positive outcomes after procedures such as PCI and stent placement, while some users share mixed experiences with tolerability.

Pharmacists and community clinics are frequently recommended in threads for counselling and medication reviews.

Reported Benefits And Challenges From Canadian Patients

Patients report relief knowing clopidogrel lowers the chance of recurrent heart attack or stroke after stent placement.

Common patient-reported challenges include bruising, concerns about bleeding during dental work, and costs when not covered by provincial plans.

Top 5 Patient-Reported Pros:

• Reduced risk of recurrent myocardial infarction and stroke after PCI.
• Once-daily dosing is convenient.
• Generic affordability when covered or substituted.
• Pharmacist counselling improves adherence.
• Peace of mind after stent placement.

Top 5 Patient-Reported Cons:

• Easy bruising and minor bleeding.
• Worry about bleeding before dental procedures.
• Potential reduced effect in people with CYP2C19 loss-of-function alleles.
• Cost or coverage gaps for some patients.
• Delays filling prescriptions in rural communities.

Anecdotal Quotes Box:

• "After my stent I felt safer taking clopidogrel, but my dentist wanted it stopped before a cleaning."
• "The generic from Teva worked fine and saved me money compared to Plavix."
• "I bruised easily, so the pharmacist reviewed my other meds and supplements."

Product Overview & Brand Variants

INN And Brand Names Used In Canada

The International Nonproprietary Name is clopidogrel, and the ATC code is B01AC04.

Plavix is the original brand, and numerous generics exist worldwide including Clopidogrel Teva, Clopidogrel Mylan and products from KRKA, Apotex and Sandoz.

In many markets generics have largely replaced routine dispensing of the brand-name product, though Plavix remains a known trade name.

Legal Classification Under Health Canada

Clopidogrel is a prescription-only medicine (Rx) and is not available over the counter.

Each marketed product in Canada carries a Drug Identification Number (DIN) which confirms Health Canada approval and allows patients to verify the exact product and manufacturer.

Pharmacists can explain DIN differences and whether interchange is permitted under provincial substitution policies.

• INN: Clopidogrel.
• ATC Code: B01AC04.
• DIN: Check the label or Health Canada Drug Product Database for the exact DIN of the dispensed product.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

Clopidogrel is used to prevent atherothrombotic events in acute coronary syndromes and after percutaneous coronary intervention including stent placement.

The medicine is also indicated for secondary prevention after myocardial infarction, ischaemic stroke and for peripheral arterial disease.

Typical dosing follows a loading dose of 300–600 mg for urgent ACS/PCI and maintenance therapy of 75 mg once daily.

Off-Label Patterns In Canadian Healthcare

Off-label uses are uncommon because approved indications are well defined.

Clinicians may individualize antiplatelet duration, including shorter dual antiplatelet therapy (DAPT) regimens in selected low-risk patients after stent placement.

Common Off-Label Scenarios:

• Tailored DAPT duration after certain stents.
• De-escalation from ticagrelor/prasugrel to clopidogrel under specialist oversight.
• Use in combination with aspirin when clinically indicated for secondary prevention.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

Clopidogrel is an antiplatelet medicine that helps stop blood clots by making platelets less sticky.

After a heart attack or stent, clopidogrel lowers the chance that another clot will form and block blood flow.

The tablet is a prodrug, which means the liver must convert it into an active form before it fully works.

Patients usually feel the protection after the loading dose and during daily maintenance dosing.

Clinical Detail From Health Canada Resources

The mechanism is inhibition of the platelet P2Y12 ADP receptor, which reduces platelet aggregation.

Conversion to the active metabolite depends on hepatic cytochrome P450 enzymes, notably CYP2C19, which causes variable response in people with loss-of-function alleles.

Clinical implications include possible reduced efficacy in CYP2C19 poor metabolizers and potential drug interactions with some proton-pump inhibitors and other medicines.

• Prodrug: requires liver activation.
• CYP2C19: enzyme affecting activation and response.
• P2Y12: platelet receptor targeted by clopidogrel.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

For acute coronary syndromes and PCI, a loading dose of 300–600 mg is recommended, commonly 300 mg when given with aspirin and 600 mg in urgent PCI situations.

Maintenance therapy is 75 mg once daily for most indications.

For ischaemic stroke or peripheral arterial disease, treatment typically begins with 75 mg once daily without a loading dose.

Adjustments By Patient Type (With Canadian Clinical Notes)

Clopidogrel is not approved for children; safety and efficacy are not established.

Elderly patients require no routine dose change, but bleeding risk is higher and monitoring is prudent.

Renal impairment generally does not require dose adjustment for mild to moderate dysfunction, but exercise caution in severe impairment.

Hepatic impairment warrants caution; severe liver disease is a relative contraindication because bleeding risk may increase.

• Missed Dose: Take as soon as remembered unless close to next dose; do not double up.
• Overdose: Increased bleeding risk; supportive care and platelet transfusion may be considered; no specific antidote exists.
• Monitoring Checklist: regular medication review, bleeding assessment, review of OTC NSAIDs and anticoagulants.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Absolute contraindications include active pathological bleeding such as peptic ulcer or intracranial haemorrhage and known hypersensitivity to clopidogrel or excipients.

Common adverse effects are easy bruising, minor bleeding (nosebleeds, gum bleeding), gastrointestinal upset including diarrhoea and dyspepsia.

Less common effects include rash, itching, headache and dizziness.

Rare But Serious (With Canadian Pharmacovigilance Data)

Serious but rare reactions can include gastrointestinal or intracranial haemorrhage, neutropenia and thrombotic thrombocytopenic purpura (TTP).

Health Canada collects reports through Canada Vigilance and MedEffect, and clinicians should report suspected serious events.

When To Seek Help:

• Call emergency services or go to emergency if you have severe bleeding, fainting, severe headache or sudden weakness.
• Contact your pharmacist or prescriber for persistent nosebleeds, blood in stool or urine, or unexplained bruising.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Always check the exact DIN on the product label or Health Canada’s Drug Product Database before substitution.

Pros And Cons List

Clopidogrel has a long track record, affordable generic options and a once-daily dosing schedule.

Its main drawbacks are variable metabolism due to CYP2C19 and a more modest antiplatelet effect compared with ticagrelor or prasugrel.

Decision Factors Checklist:

• Clinical ischaemic vs bleeding risk.
• Provincial formulary coverage and patient cost.
• Drug interactions and patient tolerance.
• Availability of pharmacogenetic testing in specific centres.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

Recent research emphasizes genotype-guided antiplatelet therapy, optimal DAPT duration and de-escalation strategies such as switching from ticagrelor/prasugrel to clopidogrel.

Genotype-guided approaches using CYP2C19 testing have shown promise in personalizing therapy to reduce bleeding without increasing ischaemic events in selected trials up to 2024.

Canadian centres participate in registries monitoring real-world outcomes with generics and adherence patterns.

Key Study Themes & Takeaways:

• Genotype-guided therapy may reduce bleeding events for some patients.
• Shorter DAPT is being studied for select low-risk patients after newer-generation stent implantation.
• Point-of-care CYP2C19 testing is gaining interest but is not yet routine across Canada.

Trend Notes

Guideline updates increasingly recommend patient-centred protocols and tailored DAPT duration based on bleeding and ischaemic risk.

Cost-effectiveness analyses are relevant to provincial drug plans deciding on preferred agents.

Keep product pages and counselling materials updated with links to major guideline changes and Canadian society statements when available.

Common Patient Questions In Canada

Can I get clopidogrel without a prescription?

No; clopidogrel is prescription-only across Canada and pharmacists cannot dispense it without a valid prescription.

Will my provincial drug plan cover it?

Coverage depends on the province and patient eligibility; Ontario Drug Benefit, BC PharmaCare and RAMQ may cover clopidogrel for qualifying patients and indications.

Is generic as effective as Plavix?

Generics approved by Health Canada must meet bioequivalence standards and carry a DIN; pharmacists can explain manufacturer differences and substitution options such as Teva-Clopidogrel or Apo-Clopidogrel.

What about stopping before dental work or surgery?

Typically, clopidogrel is stopped 5–7 days before procedures with bleeding risk, but patients must consult the prescribing physician or surgeon before stopping antiplatelet therapy.

• FAQ Action Items: show your prescription card at the pharmacy, ask about provincial coverage, consult prescriber before stopping medication, and report major bleeding immediately.

Regulatory Status

Health Canada Approval Process

Products containing clopidogrel are reviewed for safety, efficacy and quality before market authorization by Health Canada or equivalent regulatory bodies.

Approvals are recorded with a Drug Identification Number (DIN) that identifies formulation, strength and manufacturer.

Post-market surveillance is ongoing and adverse events are tracked through national programs.

DIN Number Relevance

The DIN is essential for verifying product authenticity and for claims to provincial drug plans.

Patients and pharmacists can check Health Canada’s Drug Product Database by DIN to confirm the active ingredient, strength, and manufacturer details such as 75 mg and 300 mg formulations.

• DIN: product identifier for reimbursement and verification.
• NOC: Notice of Compliance details may be used in regulatory contexts.
• Canada Vigilance: channel to report suspected adverse reactions.

Visual Recommendations

Infographic Ideas For Canadian Context

Provincial Availability Map: a map showing where brand versus generics are commonly stocked and which provincial drug plans list clopidogrel would be helpful for patients and clinicians.

Dosage Flowchart: a simple flowchart guiding loading versus maintenance dosing after ACS/PCI or stroke/PAD, including common durations such as 12 months and indefinite therapy when appropriate.

Mechanism Diagram: illustrate prodrug activation via CYP2C19 and the P2Y12 receptor blockade, with interaction flags for some PPIs and SSRIs.

Side-Effect Chart: a colour-coded table showing minor versus urgent bleeding signs and when to seek help.

Comparison Table: clopidogrel versus ticagrelor versus prasugrel including dosing, pros/cons and a reminder to check DINs for specific products.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

Bring your prescription and provincial drug card when buying in-store.

Ask the pharmacist about available generics such as Teva-Clopidogrel, Mylan and Apotex, and about patient assistance programs or provincial formulary coverage.

Use Canadian-licensed online pharmacies only and verify the pharmacy licence and that the product displays a DIN.

Be cautious with cross-border purchases because of customs delays, variable formulations and possible lack of reimbursement.

• Online Vendor Verification Checklist: check for a Canadian pharmacy licence, visible DIN on the product page, secure payment and clear contact information.
• Note: In our online pharmacy, clopidogrel is available without a prescription, with discreet delivery to Canada in 5-14 days.

Proper Storage With Canadian Climate Considerations

Store clopidogrel at room temperature between 15–30°C, protected from moisture and light.

Avoid storing tablets in vehicles in winter or in bathrooms where humidity is high.

Keep tablets in their original packaging to reduce moisture exposure and for easy reference to the DIN and expiry date.

Travel Checklist: carry a copy of the prescription, pharmacist contact information and the original packaging when crossing provincial borders within Canada.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

Use a simple clinician checklist to counsel patients on indication, dose (loading and maintenance), expected duration and bleeding precautions.

Discuss relevant drug interactions such as NSAIDs, concomitant anticoagulants and certain PPIs, and review what to do with missed doses.

Encourage shared decision-making about the duration of dual antiplatelet therapy, particularly after stent placement.

• Counselling Checklist: explain indication, dosing schedule, expected duration, bleeding signs, interactions, missed dose advice and perioperative plans.
• Monitoring: arrange medication reviews, watch for bruising or bleeding, review OTC meds and consider pharmacogenetic referral if poor response is suspected.

Special Populations: for pregnant or breastfeeding patients or those with severe liver disease, discuss risks and refer to specialists as appropriate.

Delivery Across Canada (English)